It also displayed promising effects on MDR cancer cells, including HL60 cells resistant to adriamycin, vincristine, and mitoxantrone, ovarian carcinoma cell line resistant to cisplatin, small lung carcinoma cell line GLC4 resistant to adriamycin, and the human colon cancer HCT116 p53 (-/-) delete clone [21]. Here, TP53 is linked to cancer.